Cell free preparations of probiotics exerted antibacterial and antibiofilm activities against multidrug resistant E. coli
The sharp increase in antibiotic resistance imposes a global threat to human health and the discovery of effective antimicrobial alternatives is needed. The use of probiotics to combat bacterial pathogens has gained a rising interest. Pathogenic Escherichia coli is causative of multiple clinical syn...
Saved in:
| Published in: | Saudi pharmaceutical journal Vol. 26; no. 5; pp. 603 - 607 |
|---|---|
| Main Authors: | , , |
| Format: | Journal Article |
| Language: | English |
| Published: |
Saudi Arabia
Elsevier B.V
01-07-2018
Elsevier |
| Subjects: | |
| Online Access: | Get full text |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
| Abstract | The sharp increase in antibiotic resistance imposes a global threat to human health and the discovery of effective antimicrobial alternatives is needed. The use of probiotics to combat bacterial pathogens has gained a rising interest. Pathogenic Escherichia coli is causative of multiple clinical syndromes such as diarrheal diseases, meningitis and urinary tract infections. In this work, we evaluated the efficacy of probiotics to control multidrug-resistant E. coli and reduce their ability to form biofilms. Six E. coli resistant to at least five antibiotics (Ceftazidime, Ampicillin, Clarithromycin, Amoxicillin + Clavulanic Acid and Ceftriaxone) were isolated in this work. Preparations of cell-free spent media (CFSM) of six probiotics belonging to the genus Bifidobacterium and Lactobacillus which were grown in Man-Rogosa-Sharpe (MRS) broth exhibited strong antibacterial activity (inhibition zones of 11.77–23.10 mm) against all E. coli isolates. Two E. coli isolates, namely E. coli WW1 and IC2, which were most resistant to all antibiotics were subjected to antibiofilm experiments. Interestingly, the CFSM of MRS fermented by all probiotics resulted in inhibition of biofilm formation while B. longum caused highest inhibition (57.94%) in case of E. coli IC2 biofilms and L. plantarum was responsible for 64.57% reduction of E. coli WW1 biofilms. On the other hand, CFSM of skim milk fermented by L. helveticus and L. rhamnosus exhibited a slight inhibitory activity against IC2 isolate (inhibition percentage of 31.52 and 17. 68, respectively) while WW1 isolate biofilms was reduced by CFSM of milk fermented by B. longum and L. helveticus (70.81 and 69.49 reduction percentage, respectively). These results support the effective use of probiotics as antimicrobial alternatives and to eradicate biofilms formed by multidrug-resistant E. coli. |
|---|---|
| AbstractList | The sharp increase in antibiotic resistance imposes a global threat to human health and the discovery of effective antimicrobial alternatives is needed. The use of probiotics to combat bacterial pathogens has gained a rising interest. Pathogenic Escherichia coli is causative of multiple clinical syndromes such as diarrheal diseases, meningitis and urinary tract infections. In this work, we evaluated the efficacy of probiotics to control multidrug-resistant E. coli and reduce their ability to form biofilms. Six E. coli resistant to at least five antibiotics (Ceftazidime, Ampicillin, Clarithromycin, Amoxicillin + Clavulanic Acid and Ceftriaxone) were isolated in this work. Preparations of cell-free spent media (CFSM) of six probiotics belonging to the genus Bifidobacterium and Lactobacillus which were grown in Man-Rogosa-Sharpe (MRS) broth exhibited strong antibacterial activity (inhibition zones of 11.77–23.10 mm) against all E. coli isolates. Two E. coli isolates, namely E. coli WW1 and IC2, which were most resistant to all antibiotics were subjected to antibiofilm experiments. Interestingly, the CFSM of MRS fermented by all probiotics resulted in inhibition of biofilm formation while B. longum caused highest inhibition (57.94%) in case of E. coli IC2 biofilms and L. plantarum was responsible for 64.57% reduction of E. coli WW1 biofilms. On the other hand, CFSM of skim milk fermented by L. helveticus and L. rhamnosus exhibited a slight inhibitory activity against IC2 isolate (inhibition percentage of 31.52 and 17. 68, respectively) while WW1 isolate biofilms was reduced by CFSM of milk fermented by B. longum and L. helveticus (70.81 and 69.49 reduction percentage, respectively). These results support the effective use of probiotics as antimicrobial alternatives and to eradicate biofilms formed by multidrug-resistant E. coli. Keywords: Probiotics, Lactobacillus, Bifidobacterium, Multidrug resistance, E. coli The sharp increase in antibiotic resistance imposes a global threat to human health and the discovery of effective antimicrobial alternatives is needed. The use of probiotics to combat bacterial pathogens has gained a rising interest. Pathogenic Escherichia coli is causative of multiple clinical syndromes such as diarrheal diseases, meningitis and urinary tract infections. In this work, we evaluated the efficacy of probiotics to control multidrug-resistant E. coli and reduce their ability to form biofilms. Six E. coli resistant to at least five antibiotics (Ceftazidime, Ampicillin, Clarithromycin, Amoxicillin + Clavulanic Acid and Ceftriaxone) were isolated in this work. Preparations of cell-free spent media (CFSM) of six probiotics belonging to the genus Bifidobacterium and Lactobacillus which were grown in Man-Rogosa-Sharpe (MRS) broth exhibited strong antibacterial activity (inhibition zones of 11.77–23.10 mm) against all E. coli isolates. Two E. coli isolates, namely E. coli WW1 and IC2, which were most resistant to all antibiotics were subjected to antibiofilm experiments. Interestingly, the CFSM of MRS fermented by all probiotics resulted in inhibition of biofilm formation while B. longum caused highest inhibition (57.94%) in case of E. coli IC2 biofilms and L. plantarum was responsible for 64.57% reduction of E. coli WW1 biofilms. On the other hand, CFSM of skim milk fermented by L. helveticus and L. rhamnosus exhibited a slight inhibitory activity against IC2 isolate (inhibition percentage of 31.52 and 17. 68, respectively) while WW1 isolate biofilms was reduced by CFSM of milk fermented by B. longum and L. helveticus (70.81 and 69.49 reduction percentage, respectively). These results support the effective use of probiotics as antimicrobial alternatives and to eradicate biofilms formed by multidrug-resistant E. coli. The sharp increase in antibiotic resistance imposes a global threat to human health and the discovery of effective antimicrobial alternatives is needed. The use of probiotics to combat bacterial pathogens has gained a rising interest. Pathogenic Escherichia coli is causative of multiple clinical syndromes such as diarrheal diseases, meningitis and urinary tract infections. In this work, we evaluated the efficacy of probiotics to control multidrug-resistant E. coli and reduce their ability to form biofilms. Six E. coli resistant to at least five antibiotics (Ceftazidime, Ampicillin, Clarithromycin, Amoxicillin + Clavulanic Acid and Ceftriaxone) were isolated in this work. Preparations of cell-free spent media (CFSM) of six probiotics belonging to the genus Bifidobacterium and Lactobacillus which were grown in Man-Rogosa-Sharpe (MRS) broth exhibited strong antibacterial activity (inhibition zones of 11.77–23.10 mm) against all E. coli isolates. Two E. coli isolates, namely E. coli WW1 and IC2, which were most resistant to all antibiotics were subjected to antibiofilm experiments. Interestingly, the CFSM of MRS fermented by all probiotics resulted in inhibition of biofilm formation while B. longum caused highest inhibition (57.94%) in case of E. coli IC2 biofilms and L. plantarum was responsible for 64.57% reduction of E. coli WW1 biofilms. On the other hand, CFSM of skim milk fermented by L. helveticus and L. rhamnosus exhibited a slight inhibitory activity against IC2 isolate (inhibition percentage of 31.52 and 17. 68, respectively) while WW1 isolate biofilms was reduced by CFSM of milk fermented by B. longum and L. helveticus (70.81 and 69.49 reduction percentage, respectively). These results support the effective use of probiotics as antimicrobial alternatives and to eradicate biofilms formed by multidrug-resistant E. coli . The sharp increase in antibiotic resistance imposes a global threat to human health and the discovery of effective antimicrobial alternatives is needed. The use of probiotics to combat bacterial pathogens has gained a rising interest. Pathogenic is causative of multiple clinical syndromes such as diarrheal diseases, meningitis and urinary tract infections. In this work, we evaluated the efficacy of probiotics to control multidrug-resistant and reduce their ability to form biofilms. Six resistant to at least five antibiotics (Ceftazidime, Ampicillin, Clarithromycin, Amoxicillin + Clavulanic Acid and Ceftriaxone) were isolated in this work. Preparations of cell-free spent media (CFSM) of six probiotics belonging to the genus and which were grown in Man-Rogosa-Sharpe (MRS) broth exhibited strong antibacterial activity (inhibition zones of 11.77-23.10 mm) against all isolates. Two isolates, namely WW1 and IC2, which were most resistant to all antibiotics were subjected to antibiofilm experiments. Interestingly, the CFSM of MRS fermented by all probiotics resulted in inhibition of biofilm formation while caused highest inhibition (57.94%) in case of IC2 biofilms and was responsible for 64.57% reduction of WW1 biofilms. On the other hand, CFSM of skim milk fermented by and exhibited a slight inhibitory activity against IC2 isolate (inhibition percentage of 31.52 and 17. 68, respectively) while WW1 isolate biofilms was reduced by CFSM of milk fermented by and (70.81 and 69.49 reduction percentage, respectively). These results support the effective use of probiotics as antimicrobial alternatives and to eradicate biofilms formed by multidrug-resistant . |
| Author | Abdelhamid, Ahmed G. Esaam, Aliaa Hazaa, Mahmoud M. |
| AuthorAffiliation | Botany Department, Faculty of Science, Benha University, Benha 13518, Egypt |
| AuthorAffiliation_xml | – name: Botany Department, Faculty of Science, Benha University, Benha 13518, Egypt |
| Author_xml | – sequence: 1 givenname: Ahmed G. surname: Abdelhamid fullname: Abdelhamid, Ahmed G. email: ahmed.abdelhamid@fsc.bu.edu.eg – sequence: 2 givenname: Aliaa surname: Esaam fullname: Esaam, Aliaa – sequence: 3 givenname: Mahmoud M. surname: Hazaa fullname: Hazaa, Mahmoud M. |
| BackLink | https://www.ncbi.nlm.nih.gov/pubmed/29991904$$D View this record in MEDLINE/PubMed |
| BookMark | eNp9UcFuEzEQtVARTQs_wAH5yCWL7bV31xJCQlFpK1XiAmfLa4_DRJt1sJ2I_j0OCRW9cLJn5r3n53lX5GKOMxDylrOGM9592DSbvMuNYHxoWNswJl-QhRC8XfayVxdkwVuulxUpL8lVzhvGhFK6fUUuhdaaayYX5HEF00RDAqC7BDubbME4ZxpDreOIsaDLFH5BKuCpnQuO1hVIaKdanTsYA05bWgd4wIKQqV1bnHOh2_1U0Kf9mibImEuF05uGujjha_Iy2CnDm_N5Tb5_ufm2uls-fL29X31-WDoleFnC4EMXOHQOrNZeae7syKXQvmetcmocne5Bjar6klr64AflmQiD7FllDu01uT_p-mg3Zpdwa9OjiRbNn0ZMa2NT_eUEJnDOhdWgmbKy68UwaDUOzotwvDtZtT6dtHb7cQvewVySnZ6JPp_M-MOs48F01Wvbsirw_iyQ4s895GK2mF2NwM4Q99kIVh3LrutEhYoT1KWYc4Lw9Axn5pi_2Zhj_uaYv2GtqflX0rt_DT5R_gZeAR9PAKgrPyAkkx3C7MBjAlfqTvB_-r8BhvrHdg |
| CitedBy_id | crossref_primary_10_1007_s12602_023_10062_w crossref_primary_10_22207_JPAM_16_3_28 crossref_primary_10_2147_IDR_S413416 crossref_primary_10_3390_cancers12082272 crossref_primary_10_1016_j_sjbs_2021_02_017 crossref_primary_10_3390_antibiotics11020154 crossref_primary_10_1016_j_actatropica_2022_106669 crossref_primary_10_1007_s11908_022_00795_0 crossref_primary_10_1016_j_cofs_2020_03_009 crossref_primary_10_3390_agriculture10090368 crossref_primary_10_37442_fme_2023_3_23 crossref_primary_10_1186_s13287_022_03151_0 crossref_primary_10_3389_fmicb_2024_1358456 crossref_primary_10_3390_microorganisms8101510 crossref_primary_10_1007_s00284_022_03061_7 crossref_primary_10_1016_j_micpath_2020_104029 crossref_primary_10_3390_antibiotics9090630 crossref_primary_10_1080_09637486_2020_1857710 crossref_primary_10_1007_s12094_021_02738_y crossref_primary_10_1016_j_meafoo_2024_100171 crossref_primary_10_1039_D3RA08667D crossref_primary_10_5817_CSF2021_6_206 crossref_primary_10_1007_s13167_019_00184_z crossref_primary_10_30841_2307_5112_4_2021_249409 crossref_primary_10_3390_pathogens12121449 crossref_primary_10_3389_fmicb_2023_1108273 crossref_primary_10_1016_j_archoralbio_2022_105515 crossref_primary_10_1186_s12906_022_03775_y crossref_primary_10_1016_j_envres_2021_110897 crossref_primary_10_1093_lambio_ovac006 crossref_primary_10_1016_j_tifs_2023_04_013 crossref_primary_10_1186_s13568_021_01320_7 crossref_primary_10_1007_s12602_020_09724_w crossref_primary_10_1016_j_jsps_2020_10_002 crossref_primary_10_1080_19490976_2024_2357176 crossref_primary_10_3390_microorganisms8020177 crossref_primary_10_4014_jmb_2007_07046 crossref_primary_10_4014_jmb_2306_06001 crossref_primary_10_3389_fnut_2021_634897 crossref_primary_10_3390_nu15030709 crossref_primary_10_3389_fbioe_2021_770248 crossref_primary_10_1016_j_bcab_2024_103101 crossref_primary_10_1007_s11033_020_05508_1 crossref_primary_10_3389_fmicb_2021_631627 crossref_primary_10_1007_s10311_021_01382_w crossref_primary_10_1016_j_ijbiomac_2019_06_011 crossref_primary_10_1128_msystems_00757_22 crossref_primary_10_1016_j_jff_2020_104080 crossref_primary_10_1016_j_cmi_2022_08_010 crossref_primary_10_20517_2394_4722_2023_178 crossref_primary_10_1016_j_dentre_2022_100040 |
| Cites_doi | 10.1016/j.jiac.2016.02.004 10.1007/978-3-540-75418-3_12 10.1097/AOG.0b013e3181726f2f 10.1002/ibd.20377 10.1016/S0924-8579(99)00074-6 10.1128/JB.00464-07 10.1016/j.anaerobe.2012.08.004 10.1016/j.ijfoodmicro.2012.03.034 10.1177/0884533608331177 10.1128/AEM.68.6.2950-2958.2002 10.1111/joim.12004 10.1086/599831 10.1128/AEM.00159-07 10.1021/jf001237h 10.1128/CMR.18.4.657-686.2005 10.1016/j.ijfoodmicro.2008.04.012 10.1016/j.foodcont.2012.05.071 10.1016/j.anaerobe.2013.09.011 10.1111/j.1469-0691.2011.03570.x 10.1007/s10620-008-0361-4 10.1345/aph.1P790 10.1016/j.bbrc.2008.12.053 10.1038/nrmicro818 10.1038/ijos.2014.52 10.1007/s12602-016-9223-0 10.3201/eid0402.980212 10.3201/eid1805.111153 10.1038/nrmicro2953 10.1007/s00705-012-1543-0 10.1016/j.gtc.2012.08.002 10.1128/AEM.01651-08 10.1186/1471-2180-9-202 10.1016/B978-0-12-369408-9.00051-2 |
| ContentType | Journal Article |
| Copyright | 2018 The Authors 2018 The Authors 2018 |
| Copyright_xml | – notice: 2018 The Authors – notice: 2018 The Authors 2018 |
| DBID | 6I. AAFTH NPM AAYXX CITATION 7X8 5PM DOA |
| DOI | 10.1016/j.jsps.2018.03.004 |
| DatabaseName | ScienceDirect Open Access Titles Elsevier:ScienceDirect:Open Access PubMed CrossRef MEDLINE - Academic PubMed Central (Full Participant titles) Directory of Open Access Journals |
| DatabaseTitle | PubMed CrossRef MEDLINE - Academic |
| DatabaseTitleList | PubMed |
| Database_xml | – sequence: 1 dbid: DOA name: Directory of Open Access Journals url: http://www.doaj.org/ sourceTypes: Open Website |
| DeliveryMethod | fulltext_linktorsrc |
| Discipline | Chemistry Pharmacy, Therapeutics, & Pharmacology |
| EISSN | 2213-7475 |
| EndPage | 607 |
| ExternalDocumentID | oai_doaj_org_article_f1112a9e905a46728895b8cd2f7288c4 10_1016_j_jsps_2018_03_004 29991904 S1319016418300677 |
| Genre | Journal Article |
| GroupedDBID | --- --K 0R~ 0SF 123 1B1 4.4 457 53G 5VS 6I. 71M AACTN AAEDT AAEDW AAFTH AAIKJ AALRI AAQFI AAXUO ABMAC ACGFO ACGFS ADBBV ADEZE ADMUD AENEX AEXQZ AFTJW AGHFR AITUG ALMA_UNASSIGNED_HOLDINGS AMRAJ BAWUL BCNDV DIK DU5 E3Z EBS EJD EP3 FDB FEDTE FNPLU GROUPED_DOAJ GX1 HH5 HVGLF HYE HZ~ IPNFZ IXB KQ8 NCXOZ O-L O9- OK1 OZT P2P RIG ROL RPM SES SSZ TR2 XH2 ~S- ADVLN AFJKZ AKRWK NPM AAYXX CITATION 7X8 5PM |
| ID | FETCH-LOGICAL-c521t-e8df6f1e6cea99d591cab1429d7035c5bbc97e5b5bac494dfd85d02f8470df683 |
| IEDL.DBID | RPM |
| ISSN | 1319-0164 |
| IngestDate | Tue Oct 22 15:15:46 EDT 2024 Tue Sep 17 20:36:09 EDT 2024 Sat Oct 26 00:32:39 EDT 2024 Thu Sep 26 16:12:13 EDT 2024 Wed Oct 16 01:00:16 EDT 2024 Fri Feb 23 02:34:39 EST 2024 |
| IsDoiOpenAccess | true |
| IsOpenAccess | true |
| IsPeerReviewed | true |
| IsScholarly | true |
| Issue | 5 |
| Keywords | Probiotics Bifidobacterium Multidrug resistance E. coli Lactobacillus |
| Language | English |
| License | This is an open access article under the CC BY-NC-ND license. This is an open access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/). |
| LinkModel | DirectLink |
| MergedId | FETCHMERGED-LOGICAL-c521t-e8df6f1e6cea99d591cab1429d7035c5bbc97e5b5bac494dfd85d02f8470df683 |
| Notes | ObjectType-Article-1 SourceType-Scholarly Journals-1 ObjectType-Feature-2 content type line 23 |
| OpenAccessLink | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6035330/ |
| PMID | 29991904 |
| PQID | 2068346662 |
| PQPubID | 23479 |
| PageCount | 5 |
| ParticipantIDs | doaj_primary_oai_doaj_org_article_f1112a9e905a46728895b8cd2f7288c4 pubmedcentral_primary_oai_pubmedcentral_nih_gov_6035330 proquest_miscellaneous_2068346662 crossref_primary_10_1016_j_jsps_2018_03_004 pubmed_primary_29991904 elsevier_sciencedirect_doi_10_1016_j_jsps_2018_03_004 |
| PublicationCentury | 2000 |
| PublicationDate | 2018-07-01 |
| PublicationDateYYYYMMDD | 2018-07-01 |
| PublicationDate_xml | – month: 07 year: 2018 text: 2018-07-01 day: 01 |
| PublicationDecade | 2010 |
| PublicationPlace | Saudi Arabia |
| PublicationPlace_xml | – name: Saudi Arabia |
| PublicationTitle | Saudi pharmaceutical journal |
| PublicationTitleAlternate | Saudi Pharm J |
| PublicationYear | 2018 |
| Publisher | Elsevier B.V Elsevier |
| Publisher_xml | – name: Elsevier B.V – name: Elsevier |
| References | Torres, A.G., 2009. Intestinal pathogenic Escherichia coli. In: Vaccines for Biodefense and Emerging and Neglected Diseases. pp. 1013–1029. Wall, Schirmer, Anliker, Tigges (b0185) 2011; 45 Li, Liu, Chen, Li, Cui, Kan, Ma, Cui (b0095) 2017; 38 Nakai, Hagihara, Kato, Hirai, Nishiyama, Koizumi, Sakanashi, Suematsu, Yamagishi, Mikamo (b0130) 2016; 22 Alfaleh, K., Anabrees, J., Bassler, D., Al-Kharfi, T., 2011. Probiotics for prevention of necrotizing enterocolitis in preterm infants. Cochrane Database Syst. Rev. CD005496. Vuotto, C., Longo, F., Donelli, G., 2014. Probiotics to counteract biofilm-associated infections: Promising and conflicting data. Int. J. Oral Sci. Cruz, Domínguez, Domínguez, Parajó (b0050) 2001; 49 Croxen, Brett Finlay (b0045) 2012; 11 Yang, Lin, Sung, Fang (b0195) 2014; 5 Beloin, C., Roux, A., Ghigo, J.M., 2008. Escherichia coli biofilms. Curr. Top. Microbiol. Immunol. Medellin-Peña, Griffiths (b0115) 2009; 75 Kaper, Nataro, Harry, Mobley (b0085) 2004; 2 Minocha (b0120) 2009; 24 Kaboosi (b0080) 2011; 5 Biemer (b0025) 1973; 3 Tejero-Sariñena, Barlow, Costabile, Gibson, Rowland (b0170) 2012; 18 Martinez-Medina, Naves, Blanco, Aldeguer, Blanco, Blanco, Ponte, Soriano, Darfeuille-Michaud, Garcia-Gil (b0105) 2009; 9 Collignon (b0040) 2009; 49 Magiorakos, Srinivasan, Carey, Carmeli, Falagas, Giske, Harbarth, Hindler, Kahlmeter, Olsson-Liljequist, Paterson, Rice, Stelling, Struelens, Vatopoulos, Weber, Monnet (b0100) 2012; 18 Erdem, Avelino, Xicohtencatl-Cortes, Giron, Giron (b0065) 2007; 189 Friedman, G., 2012. The role of probiotics in the prevention and treatment of antibiotic-associated diarrhea and Clostridium Difficile colitis. Gastroenterol. Clin. North Am. Djordjevic, Wiedmann, McLandsborough (b0055) 2002; 68 Noordiana, Fatimah, Mun (b0140) 2013; 20 Yang, Huang, Qin, Wu, Zhao, Chen (b0190) 2009; 54 Tadesse, D.A., Zhao, S., Tong, E., Ayers, S., Singh, A., Bartholomew, M.J., McDermott, P.F., 2012. Antimicrobial drug resistance in Escherichia coli from humans and food animals, United States, 1950–2002. Emerg. Infect. Dis. Römling, Balsalobre (b0150) 2012 Chai, Burwinkel, Wang, Palissa, Esch, Twardziok, Rieger, Wrede, Schmidt (b0035) 2013; 158 Nataro, J.P., Steiner, T., Guerrant, R.L., 1998. Enteroaggregative Escherichia coli. Emerg. Infect. Dis. . Jadhav, Shah, Bhave, Palombo (b0075) 2013; 29 Mubita, Syakalima, Chisenga, Munyeme, Bwalya, Chifumpa, Hang’ombe, Sinkala, Simuunza, Fukushi, Isogai, Yasuda, Isogai (b0125) 2008; 78 Candela, Perna, Carnevali, Vitali, Ciati, Gionchetti, Rizzello, Campieri, Brigidi (b0030) 2008; 125 Drider, Bendali, Naghmouchi, Chikindas (b0060) 2016; 8 Paterson, Bonomo (b0145) 2005; 18 Schultz, M., 2008. Clinical use of E. coli Nissle 1917 in inflammatory bowel disease. Inflamm. Bowel Dis. Kim, oh, Kim (b0090) 2009; 379 Bayoumi, Griffiths (b0015) 2012; 156 Tejero-Sariñena, Barlow, Costabile, Gibson, Rowland (b0165) 2013; 24 Medellin-Pena, Wang, Johnson, Anand, Griffiths (b0110) 2007; 73 Arora, Kaur (b0010) 1999; 12 Wall (10.1016/j.jsps.2018.03.004_b0185) 2011; 45 Yang (10.1016/j.jsps.2018.03.004_b0190) 2009; 54 Magiorakos (10.1016/j.jsps.2018.03.004_b0100) 2012; 18 Erdem (10.1016/j.jsps.2018.03.004_b0065) 2007; 189 10.1016/j.jsps.2018.03.004_b0070 Medellin-Peña (10.1016/j.jsps.2018.03.004_b0115) 2009; 75 10.1016/j.jsps.2018.03.004_b0175 Yang (10.1016/j.jsps.2018.03.004_b0195) 2014; 5 10.1016/j.jsps.2018.03.004_b0155 Kaboosi (10.1016/j.jsps.2018.03.004_b0080) 2011; 5 Martinez-Medina (10.1016/j.jsps.2018.03.004_b0105) 2009; 9 10.1016/j.jsps.2018.03.004_b0135 Collignon (10.1016/j.jsps.2018.03.004_b0040) 2009; 49 Jadhav (10.1016/j.jsps.2018.03.004_b0075) 2013; 29 Mubita (10.1016/j.jsps.2018.03.004_b0125) 2008; 78 Tejero-Sariñena (10.1016/j.jsps.2018.03.004_b0170) 2012; 18 Paterson (10.1016/j.jsps.2018.03.004_b0145) 2005; 18 Tejero-Sariñena (10.1016/j.jsps.2018.03.004_b0165) 2013; 24 Römling (10.1016/j.jsps.2018.03.004_b0150) 2012 Chai (10.1016/j.jsps.2018.03.004_b0035) 2013; 158 Kaper (10.1016/j.jsps.2018.03.004_b0085) 2004; 2 10.1016/j.jsps.2018.03.004_b0180 Bayoumi (10.1016/j.jsps.2018.03.004_b0015) 2012; 156 Candela (10.1016/j.jsps.2018.03.004_b0030) 2008; 125 10.1016/j.jsps.2018.03.004_b0160 Minocha (10.1016/j.jsps.2018.03.004_b0120) 2009; 24 10.1016/j.jsps.2018.03.004_b0020 Djordjevic (10.1016/j.jsps.2018.03.004_b0055) 2002; 68 Noordiana (10.1016/j.jsps.2018.03.004_b0140) 2013; 20 Nakai (10.1016/j.jsps.2018.03.004_b0130) 2016; 22 Cruz (10.1016/j.jsps.2018.03.004_b0050) 2001; 49 Biemer (10.1016/j.jsps.2018.03.004_b0025) 1973; 3 10.1016/j.jsps.2018.03.004_b0005 Medellin-Pena (10.1016/j.jsps.2018.03.004_b0110) 2007; 73 Arora (10.1016/j.jsps.2018.03.004_b0010) 1999; 12 Croxen (10.1016/j.jsps.2018.03.004_b0045) 2012; 11 Kim (10.1016/j.jsps.2018.03.004_b0090) 2009; 379 Drider (10.1016/j.jsps.2018.03.004_b0060) 2016; 8 Li (10.1016/j.jsps.2018.03.004_b0095) 2017; 38 |
| References_xml | – volume: 49 start-page: 202 year: 2009 end-page: 204 ident: b0040 article-title: Resistant publication-title: Comment. Clin. Infect. Dis. contributor: fullname: Collignon – volume: 12 start-page: 257 year: 1999 end-page: 262 ident: b0010 article-title: Antimicrobial activity of spices publication-title: Int. J. Antimicrob. Agents contributor: fullname: Kaur – volume: 45 start-page: 1127 year: 2011 end-page: 1137 ident: b0185 article-title: Pharmacotherapy for acute pouchitis publication-title: Ann. Pharmacother. contributor: fullname: Tigges – volume: 22 start-page: 319 year: 2016 end-page: 326 ident: b0130 article-title: Prevalence and risk factors of infections caused by extended-spectrum β-lactamase (ESBL)-producing publication-title: J. Infect.Chemother. contributor: fullname: Mikamo – volume: 9 start-page: 202 year: 2009 ident: b0105 article-title: Biofilm formation as a novel phenotypic feature of adherent-invasive publication-title: BMC Microbiol. contributor: fullname: Garcia-Gil – volume: 189 start-page: 7426 year: 2007 end-page: 7435 ident: b0065 article-title: Host protein binding and adhesive properties of H6 and H7 flagella of attaching and effacing publication-title: J. Bacteriol. contributor: fullname: Giron – volume: 18 start-page: 657 year: 2005 end-page: 686 ident: b0145 article-title: Extended-spectrum beta-lactamases: a clinical update publication-title: Clin. Microbiol. Rev. contributor: fullname: Bonomo – volume: 3 start-page: 135 year: 1973 end-page: 140 ident: b0025 article-title: Antimicrobial susceptibility testing by the Kirby-Bauer disc diffusion method publication-title: Ann. Clin. Lab. Sci. contributor: fullname: Biemer – volume: 54 start-page: 246 year: 2009 end-page: 254 ident: b0190 article-title: Antibacterial action of selenium-enriched probiotics against pathogenic publication-title: Dig. Dis. Sci. contributor: fullname: Chen – volume: 5 start-page: 241 year: 2014 ident: b0195 article-title: Antibacterial activities of bacteriocins: application in foods and pharmaceuticals publication-title: Front. Microbiol. contributor: fullname: Fang – volume: 18 start-page: 268 year: 2012 end-page: 281 ident: b0100 article-title: Multidrug-resistant, extensively drug-resistant and pandrug-resistant bacteria: an international expert proposal for interim standard definitions for acquired resistance publication-title: Clin. Microbiol. Infect. contributor: fullname: Monnet – volume: 75 start-page: 1165 year: 2009 end-page: 1172 ident: b0115 article-title: Effect of molecules secreted by Lactobacillus acidophilus strain La-5 on publication-title: Appl. Environ. Microbiol. contributor: fullname: Griffiths – year: 2012 ident: b0150 article-title: Biofilm infections, their resilience to therapy and innovative treatment strategies publication-title: J. Intern. Med. contributor: fullname: Balsalobre – volume: 78 start-page: 179 year: 2008 end-page: 185 ident: b0125 article-title: Antibiograms of faecal publication-title: Vet. Arh. contributor: fullname: Isogai – volume: 379 start-page: 324 year: 2009 end-page: 329 ident: b0090 article-title: Released exopolysaccharide (r-EPS) produced from probiotic bacteria reduce biofilm formation of enterohemorrhagic publication-title: Biochem. Biophys. Res. Commun. contributor: fullname: Kim – volume: 11 start-page: 141 year: 2012 ident: b0045 article-title: Molecular mechanisms of publication-title: Nat. Rev. Microbiol. contributor: fullname: Brett Finlay – volume: 158 start-page: 799 year: 2013 end-page: 807 ident: b0035 article-title: Antiviral effects of a probiotic publication-title: Arch. Virol. contributor: fullname: Schmidt – volume: 5 start-page: 4363 year: 2011 end-page: 4367 ident: b0080 article-title: Antibacterial effects of probiotics isolated from yoghurts against some common bacterial pathogens publication-title: Afr. J. Microbiol. Res. contributor: fullname: Kaboosi – volume: 125 start-page: 286 year: 2008 end-page: 292 ident: b0030 article-title: Interaction of probiotic publication-title: Int. J. Food Microbiol. contributor: fullname: Brigidi – volume: 24 start-page: 227 year: 2009 end-page: 241 ident: b0120 article-title: Probiotics for preventive health publication-title: Nutr. Clin. Pract. contributor: fullname: Minocha – volume: 73 start-page: 4259 year: 2007 ident: b0110 article-title: Probiotics affect virulence-related gene expression in publication-title: Appl. Environ. Microbiol. contributor: fullname: Griffiths – volume: 29 start-page: 125 year: 2013 end-page: 130 ident: b0075 article-title: Inhibitory activity of yarrow essential oil on publication-title: Food Control contributor: fullname: Palombo – volume: 8 start-page: 177 year: 2016 end-page: 182 ident: b0060 article-title: Bacteriocins: not only antibacterial agents publication-title: Probiotics Antimicrob. Proteins contributor: fullname: Chikindas – volume: 38 start-page: 1259 year: 2017 end-page: 1262 ident: b0095 article-title: Study on antibiotic resistance of publication-title: Zhonghua Liu Xing Bing Xue Za Zhi contributor: fullname: Cui – volume: 20 start-page: 117 year: 2013 end-page: 124 ident: b0140 article-title: Antibacterial agents produced by lactic acid bacteria isolated from Threadfin Salmon and Grass Shrimp publication-title: Int. Food Res. J. contributor: fullname: Mun – volume: 18 start-page: 530 year: 2012 end-page: 538 ident: b0170 article-title: In vitro evaluation of the antimicrobial activity of a range of probiotics against pathogens: evidence for the effects of organic acids publication-title: Anaerobe contributor: fullname: Rowland – volume: 68 start-page: 2950 year: 2002 end-page: 2958 ident: b0055 article-title: Microtiter plate assay for assessment of publication-title: Appl. Environ. Microbiol. contributor: fullname: McLandsborough – volume: 24 start-page: 60 year: 2013 end-page: 65 ident: b0165 article-title: Antipathogenic activity of probiotics against publication-title: Anaerobe contributor: fullname: Rowland – volume: 49 start-page: 2459 year: 2001 end-page: 2464 ident: b0050 article-title: Antioxidant and antimicrobial effects of extracts from hydrolysates of lignocellulosic materials publication-title: J. Agric. Food Chem. contributor: fullname: Parajó – volume: 2 start-page: 123 year: 2004 ident: b0085 article-title: Pathogenic publication-title: Nat. Rev. Microbiol. contributor: fullname: Mobley – volume: 156 start-page: 255 year: 2012 end-page: 263 ident: b0015 article-title: In vitro inhibition of expression of virulence genes responsible for colonization and systemic spread of enteric pathogens using publication-title: Int. J. Food Microbiol. contributor: fullname: Griffiths – volume: 5 start-page: 4363 year: 2011 ident: 10.1016/j.jsps.2018.03.004_b0080 article-title: Antibacterial effects of probiotics isolated from yoghurts against some common bacterial pathogens publication-title: Afr. J. Microbiol. Res. contributor: fullname: Kaboosi – volume: 22 start-page: 319 year: 2016 ident: 10.1016/j.jsps.2018.03.004_b0130 article-title: Prevalence and risk factors of infections caused by extended-spectrum β-lactamase (ESBL)-producing Enterobacteriaceae publication-title: J. Infect.Chemother. doi: 10.1016/j.jiac.2016.02.004 contributor: fullname: Nakai – ident: 10.1016/j.jsps.2018.03.004_b0020 doi: 10.1007/978-3-540-75418-3_12 – ident: 10.1016/j.jsps.2018.03.004_b0005 doi: 10.1097/AOG.0b013e3181726f2f – ident: 10.1016/j.jsps.2018.03.004_b0155 doi: 10.1002/ibd.20377 – volume: 12 start-page: 257 year: 1999 ident: 10.1016/j.jsps.2018.03.004_b0010 article-title: Antimicrobial activity of spices publication-title: Int. J. Antimicrob. Agents doi: 10.1016/S0924-8579(99)00074-6 contributor: fullname: Arora – volume: 189 start-page: 7426 year: 2007 ident: 10.1016/j.jsps.2018.03.004_b0065 article-title: Host protein binding and adhesive properties of H6 and H7 flagella of attaching and effacing Escherichia coli publication-title: J. Bacteriol. doi: 10.1128/JB.00464-07 contributor: fullname: Erdem – volume: 18 start-page: 530 year: 2012 ident: 10.1016/j.jsps.2018.03.004_b0170 article-title: In vitro evaluation of the antimicrobial activity of a range of probiotics against pathogens: evidence for the effects of organic acids publication-title: Anaerobe doi: 10.1016/j.anaerobe.2012.08.004 contributor: fullname: Tejero-Sariñena – volume: 156 start-page: 255 year: 2012 ident: 10.1016/j.jsps.2018.03.004_b0015 article-title: In vitro inhibition of expression of virulence genes responsible for colonization and systemic spread of enteric pathogens using Bifidobacterium bifidum secreted molecules publication-title: Int. J. Food Microbiol. doi: 10.1016/j.ijfoodmicro.2012.03.034 contributor: fullname: Bayoumi – volume: 20 start-page: 117 year: 2013 ident: 10.1016/j.jsps.2018.03.004_b0140 article-title: Antibacterial agents produced by lactic acid bacteria isolated from Threadfin Salmon and Grass Shrimp publication-title: Int. Food Res. J. contributor: fullname: Noordiana – volume: 24 start-page: 227 year: 2009 ident: 10.1016/j.jsps.2018.03.004_b0120 article-title: Probiotics for preventive health publication-title: Nutr. Clin. Pract. doi: 10.1177/0884533608331177 contributor: fullname: Minocha – volume: 68 start-page: 2950 year: 2002 ident: 10.1016/j.jsps.2018.03.004_b0055 article-title: Microtiter plate assay for assessment of Listeria monocytogenes biofilm formation publication-title: Appl. Environ. Microbiol. doi: 10.1128/AEM.68.6.2950-2958.2002 contributor: fullname: Djordjevic – year: 2012 ident: 10.1016/j.jsps.2018.03.004_b0150 article-title: Biofilm infections, their resilience to therapy and innovative treatment strategies publication-title: J. Intern. Med. doi: 10.1111/joim.12004 contributor: fullname: Römling – volume: 49 start-page: 202 year: 2009 ident: 10.1016/j.jsps.2018.03.004_b0040 article-title: Resistant Escherichia coli—We Are What We Eat. July) @BULLET Editor publication-title: Comment. Clin. Infect. Dis. doi: 10.1086/599831 contributor: fullname: Collignon – volume: 73 start-page: 4259 year: 2007 ident: 10.1016/j.jsps.2018.03.004_b0110 article-title: Probiotics affect virulence-related gene expression in Escherichia coli O157: H7 publication-title: Appl. Environ. Microbiol. doi: 10.1128/AEM.00159-07 contributor: fullname: Medellin-Pena – volume: 49 start-page: 2459 year: 2001 ident: 10.1016/j.jsps.2018.03.004_b0050 article-title: Antioxidant and antimicrobial effects of extracts from hydrolysates of lignocellulosic materials publication-title: J. Agric. Food Chem. doi: 10.1021/jf001237h contributor: fullname: Cruz – volume: 18 start-page: 657 year: 2005 ident: 10.1016/j.jsps.2018.03.004_b0145 article-title: Extended-spectrum beta-lactamases: a clinical update publication-title: Clin. Microbiol. Rev. doi: 10.1128/CMR.18.4.657-686.2005 contributor: fullname: Paterson – volume: 125 start-page: 286 year: 2008 ident: 10.1016/j.jsps.2018.03.004_b0030 article-title: Interaction of probiotic Lactobacillus and Bifidobacterium strains with human intestinal epithelial cells: adhesion properties, competition against enteropathogens and modulation of IL-8 production publication-title: Int. J. Food Microbiol. doi: 10.1016/j.ijfoodmicro.2008.04.012 contributor: fullname: Candela – volume: 38 start-page: 1259 year: 2017 ident: 10.1016/j.jsps.2018.03.004_b0095 article-title: Study on antibiotic resistance of Escherichia coli and Enterococcus colonized in intestine of neonates from neonatal intensive care unit publication-title: Zhonghua Liu Xing Bing Xue Za Zhi contributor: fullname: Li – volume: 29 start-page: 125 year: 2013 ident: 10.1016/j.jsps.2018.03.004_b0075 article-title: Inhibitory activity of yarrow essential oil on Listeria planktonic cells and biofilms publication-title: Food Control doi: 10.1016/j.foodcont.2012.05.071 contributor: fullname: Jadhav – volume: 24 start-page: 60 year: 2013 ident: 10.1016/j.jsps.2018.03.004_b0165 article-title: Antipathogenic activity of probiotics against Salmonella Typhimurium and Clostridium difficile in anaerobic batch culture systems: is it due to synergies in probiotic mixtures or the specificity of single strains? publication-title: Anaerobe doi: 10.1016/j.anaerobe.2013.09.011 contributor: fullname: Tejero-Sariñena – volume: 18 start-page: 268 year: 2012 ident: 10.1016/j.jsps.2018.03.004_b0100 article-title: Multidrug-resistant, extensively drug-resistant and pandrug-resistant bacteria: an international expert proposal for interim standard definitions for acquired resistance publication-title: Clin. Microbiol. Infect. doi: 10.1111/j.1469-0691.2011.03570.x contributor: fullname: Magiorakos – volume: 78 start-page: 179 year: 2008 ident: 10.1016/j.jsps.2018.03.004_b0125 article-title: Antibiograms of faecal Escherichia coli and Enterococci species isolated from pastoralist cattle in the interface areas of the Kafue basin in Zambia - Short communication publication-title: Vet. Arh. contributor: fullname: Mubita – volume: 5 start-page: 241 year: 2014 ident: 10.1016/j.jsps.2018.03.004_b0195 article-title: Antibacterial activities of bacteriocins: application in foods and pharmaceuticals publication-title: Front. Microbiol. contributor: fullname: Yang – volume: 54 start-page: 246 year: 2009 ident: 10.1016/j.jsps.2018.03.004_b0190 article-title: Antibacterial action of selenium-enriched probiotics against pathogenic Escherichia coli publication-title: Dig. Dis. Sci. doi: 10.1007/s10620-008-0361-4 contributor: fullname: Yang – volume: 45 start-page: 1127 year: 2011 ident: 10.1016/j.jsps.2018.03.004_b0185 article-title: Pharmacotherapy for acute pouchitis publication-title: Ann. Pharmacother. doi: 10.1345/aph.1P790 contributor: fullname: Wall – volume: 379 start-page: 324 year: 2009 ident: 10.1016/j.jsps.2018.03.004_b0090 article-title: Released exopolysaccharide (r-EPS) produced from probiotic bacteria reduce biofilm formation of enterohemorrhagic Escherichia coli O157:H7 publication-title: Biochem. Biophys. Res. Commun. doi: 10.1016/j.bbrc.2008.12.053 contributor: fullname: Kim – volume: 2 start-page: 123 year: 2004 ident: 10.1016/j.jsps.2018.03.004_b0085 article-title: Pathogenic Escherichia coli publication-title: Nat. Rev. Microbiol. doi: 10.1038/nrmicro818 contributor: fullname: Kaper – ident: 10.1016/j.jsps.2018.03.004_b0180 doi: 10.1038/ijos.2014.52 – volume: 8 start-page: 177 year: 2016 ident: 10.1016/j.jsps.2018.03.004_b0060 article-title: Bacteriocins: not only antibacterial agents publication-title: Probiotics Antimicrob. Proteins doi: 10.1007/s12602-016-9223-0 contributor: fullname: Drider – ident: 10.1016/j.jsps.2018.03.004_b0135 doi: 10.3201/eid0402.980212 – ident: 10.1016/j.jsps.2018.03.004_b0160 doi: 10.3201/eid1805.111153 – volume: 11 start-page: 141 year: 2012 ident: 10.1016/j.jsps.2018.03.004_b0045 article-title: Molecular mechanisms of Escherichia coli pathogenicity publication-title: Nat. Rev. Microbiol. doi: 10.1038/nrmicro2953 contributor: fullname: Croxen – volume: 158 start-page: 799 year: 2013 ident: 10.1016/j.jsps.2018.03.004_b0035 article-title: Antiviral effects of a probiotic Enterococcus faecium strain against transmissible gastroenteritis coronavirus publication-title: Arch. Virol. doi: 10.1007/s00705-012-1543-0 contributor: fullname: Chai – ident: 10.1016/j.jsps.2018.03.004_b0070 doi: 10.1016/j.gtc.2012.08.002 – volume: 75 start-page: 1165 year: 2009 ident: 10.1016/j.jsps.2018.03.004_b0115 article-title: Effect of molecules secreted by Lactobacillus acidophilus strain La-5 on Escherichia coli O157:H7 colonization publication-title: Appl. Environ. Microbiol. doi: 10.1128/AEM.01651-08 contributor: fullname: Medellin-Peña – volume: 9 start-page: 202 year: 2009 ident: 10.1016/j.jsps.2018.03.004_b0105 article-title: Biofilm formation as a novel phenotypic feature of adherent-invasive Escherichia coli (AIEC) publication-title: BMC Microbiol. doi: 10.1186/1471-2180-9-202 contributor: fullname: Martinez-Medina – volume: 3 start-page: 135 year: 1973 ident: 10.1016/j.jsps.2018.03.004_b0025 article-title: Antimicrobial susceptibility testing by the Kirby-Bauer disc diffusion method publication-title: Ann. Clin. Lab. Sci. contributor: fullname: Biemer – ident: 10.1016/j.jsps.2018.03.004_b0175 doi: 10.1016/B978-0-12-369408-9.00051-2 |
| SSID | ssj0025593 |
| Score | 2.4276774 |
| Snippet | The sharp increase in antibiotic resistance imposes a global threat to human health and the discovery of effective antimicrobial alternatives is needed. The... |
| SourceID | doaj pubmedcentral proquest crossref pubmed elsevier |
| SourceType | Open Website Open Access Repository Aggregation Database Index Database Publisher |
| StartPage | 603 |
| SubjectTerms | Bifidobacterium E. coli Lactobacillus Multidrug resistance Probiotics |
| SummonAdditionalLinks | – databaseName: Directory of Open Access Journals dbid: DOA link: http://sdu.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwrV1Lb9QwEB5BL3BBUF5LARkJ9UIDcTZ27CMsW_WEKlEkbpbjR0nVZle73Ur775mJky0BCS7coiSOM5lx5ptk5huAt4VCHyB9lfGa-6z0ImTK4XpE3-NlKQsvLRUnn3ytvnxXn-dEk7Nr9UU5YYkeOD24DxEXY2F10LmwuKjx2lrUyvki0rZLTKC5GoKpPtQSiW6XdyU6GBH05TIps-tivSSibq4SvWk5ckkdc__IM_2JPH9PoPzFIx0_hAc9lGQfkwiP4E5o9-HebOjgtg-Hp4mXenvEzm7LrNZH7JCd3jJWbx_DdhYuL1lchcCWq5DYwNEa2SKyZcfTRMMYdWdCfMpQF02dSJ5xetv2expq_n3FqFDipqNpZfbcNog-WZe06Febc4axPeHV9prN3zOcvXkC347nZ7OTrO_JkDlqfZAF5aOMPEgXrNZeaO4sfUfSHl8dwom6droKohZ4H6UuffRK-LyI6ARzHKmmT2GvXbThOTDEirmVtRM2VmWuKuWImlHXlQyc-8gn8G5Qi1km6g0z5KRdGFKiISWafGpQiRP4RJrbnUm02d0ONCbTG5P5lzFNQAx6Nz0CScgCL9X8dfI3g5EY1DH9c7FtWGzoJJS5xBixmMCzZDS7WywInGsaXY3MaSTD-Ejb_OgowCU-7Ok0f_E_hD6A-yRKykF-CXvXq014BXfXfvO6W1Q_AYL5J9Q priority: 102 providerName: Directory of Open Access Journals |
| Title | Cell free preparations of probiotics exerted antibacterial and antibiofilm activities against multidrug resistant E. coli |
| URI | https://dx.doi.org/10.1016/j.jsps.2018.03.004 https://www.ncbi.nlm.nih.gov/pubmed/29991904 https://search.proquest.com/docview/2068346662 https://pubmed.ncbi.nlm.nih.gov/PMC6035330 https://doaj.org/article/f1112a9e905a46728895b8cd2f7288c4 |
| Volume | 26 |
| hasFullText | 1 |
| inHoldings | 1 |
| isFullTextHit | |
| isPrint | |
| link | http://sdu.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwnV1Nj9MwELXoXuCCYPkqLCsjob2waZM0TuwjlK72AqrEInGzHH-UrNq0SrdI_fc7Y8e7FCQO3Ko0jh3NOPMmefOGkPc5hxhQmirJ6swkhWE24Rr2I8QeUxZlbkqFxcmX36qvP_jnGcrksFgL40n7um5G7XI1apufnlu5Welx5ImN51-mZTpBUuR4QAaADWOK3mdZLCjtZr46B5KBvlImkLqutxvU6M54UDbFrjw5QiTRN2qLgcnr9x_Ep7_x5580yt_i0sUT8rgHlPRjWPhT8sC2x-ThNPZxOyZn86BOvT-nV_fFVttzekbn97rV-2dkP7XLJXWdtXTT2aAJDj5J145uvFoTDqPYowlQKgWLNHWQeobpVdsfabAF-IpiucQvL9ZK1UI1gEGppy6abregkOEjam1v6GxEYfbmOfl-MbuaXiZ9Z4ZEYwOExHLjSpfZUlslhGEi0wrfJgkDDxCmWV1rUVlWM1hHIQrjDGcmzR2EwhRG8skLctSuW_uKUECMqSprzZSripRXXKNAo6ir0maZcdmQfIhmkZsgwCEjM-1aoj0l2lOmEwn2HJJPaLm7M1E82x9YdwvZu5B08HzPlbAiZQriBLirYDXXJnf4W8NFWLS77HFIwBdwqeafk7-LTiLBxvjlRbV2vcOT4J4LyBTzIXkZnOZuidH_hqQ6cKeDezj8B_aFFwLv98Hr_x75hjzC9Qf68Qk5uul29i0ZbM3u1L-cOPVb6xZzryoc |
| link.rule.ids | 230,315,729,782,786,866,887,2108,27935,27936,53803,53805 |
| linkProvider | National Library of Medicine |
| linkToHtml | http://sdu.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwnV3Pb9MwFLbYOIwLg_Gr45eR0C4sbZLGSXyE0qmIbapEkbhZju2UTG0apStS_3ves-ONgsRhtyiJY1vvc97n5L3vEfI-zsEHpDoLoiLSQaKZCXIF6xF8j06TNNapxOTkybfs8kf-eYwyOcznwtigfVVU_Xqx7NfVTxtb2SzVwMeJDaYXozQcYlDkYI_ch_UaDv0mvdtnMae1G9n8HNgOdLkyLqzrat2gSneUO21TrMsTI0niXak275qsgv-Oh_qXgf4dSPmHZzo7vOOcHpGHHRWlH93lx-SeqY_IwchXgDsiJ1Ona709pbPbNK31KT2h01vF6-0Tsh2ZxYKWrTG0aY1TEwc001VJG6vzhM0oVncCfkvBllXhRKKhe1l3ZyosHr6kmGjxy8q8UjmXFbBXaoMedbuZ09aske_W13Tcp9B79ZR8PxvPRpOgq-kQKCydEJhcl2kZmVQZyblmPFISv0NxDa8eplhRKJ4ZVjAYR8ITXeqc6TAuwYmG0DIfPiP79ao2LwgFrhnKtFBMllkS5lmuUNqRF1lqokiXUY988OYUjZPuED6m7UogDgTiQIRDATjokU9o8Zs7UXbbnli1c9EZSpTgGWLJDQ-ZBA8DQOesyJWOSzxW8BDm8SI6BuOYCTyq-m_n7zy4BNgY_9nI2qw2eBPMOYE9Ztwjzx3Ybobocdsj2Q4Md-awewXQZyXEO7Qd37nlW3IwmV2ci_Mvl19fkgc4FxfE_IrsX7cb85rsrfXmjV2YvwH8LD6m |
| linkToPdf | http://sdu.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwpV3fb9MwELbYkICXAYNB-WkktBeWNknjJH6ErtUQMFViSLxZjn-UTG0apeuk_vfc2UlHQeIB3qLEjmPd59zn5O47Qt7GOfiAVGdBVEQ6SDQzQa5gPYLv0WmSxjqVmJx89jU7_56fjlEmZ1vqywXtq6LsV_NFvyp_uNjKeqEGXZzYYPpllIZDDIoc1NoO9shtWLMh6zbq7V6Leb3dyOXowJagzZfxoV2XqxqVuqPc65tibZ4YiRJvy7V17smp-O94qT9Z6O_BlL94p8n9_5jXA3LQUlL63jd5SG6Z6pDcHXWV4A7J8dTrW29O6MVNutbqhB7T6Y3y9eYR2YzMfE5tYwytG-NVxQHVdGlp7fSesBvFKk_AcynYtCy8WDQML6v2TIlFxBcUEy6undwrlTNZAoulLvhRN-sZbcwKeW91Rcd9CqOXj8m3yfhidBa0tR0ChSUUApNrm9rIpMpIzjXjkZL4PYpreAUxxYpC8cywgsFzJDzRVudMh7EFZxpCz3x4RParZWWeEgqcM5RpoZi0WRLmWa5Q4pEXWWqiSNuoR951JhW1l_AQXWzbpUAsCMSCCIcCsNAjH9Dq25Yov-1OLJuZaI0lLHiIWHLDQybB0wDgOStypWOLxwpuwjrMiJbJeIYCtyr_OvibDmACbIz_bmRllmtsBHNOYK8Z98gTD7jtI3bY7ZFsB4o7c9i9Agh0UuIt4p79c8_X5M70dCI-fzz_9Jzcw6n4WOYXZP-qWZuXZG-l16_c2vwJ0TdBJg |
| openUrl | ctx_ver=Z39.88-2004&ctx_enc=info%3Aofi%2Fenc%3AUTF-8&rfr_id=info%3Asid%2Fsummon.serialssolutions.com&rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&rft.genre=article&rft.atitle=Cell+free+preparations+of+probiotics+exerted+antibacterial+and+antibiofilm+activities+against+multidrug+resistant+E.+coli&rft.jtitle=Saudi+pharmaceutical+journal&rft.au=Abdelhamid%2C+Ahmed+G.&rft.au=Esaam%2C+Aliaa&rft.au=Hazaa%2C+Mahmoud+M.&rft.date=2018-07-01&rft.pub=Elsevier+B.V&rft.issn=1319-0164&rft.volume=26&rft.issue=5&rft.spage=603&rft.epage=607&rft_id=info:doi/10.1016%2Fj.jsps.2018.03.004&rft.externalDocID=S1319016418300677 |
| thumbnail_l | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/lc.gif&issn=1319-0164&client=summon |
| thumbnail_m | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/mc.gif&issn=1319-0164&client=summon |
| thumbnail_s | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/sc.gif&issn=1319-0164&client=summon |